MedPath

The efficacy of letrozole to prevent ovarian hyperstimulation symdrome

Phase 2
Recruiting
Conditions
Ovarian hyperstimulation syndorome
Registration Number
JPRN-jRCTs041190131
Lead Sponsor
Osuka Satoko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
80
Inclusion Criteria

A female between the ages of 18 and 50 who does controlled ovatian stimulation with assisted reproductive medicine. When the estradiol level is 3000 pg / ml or more on the decided day of oocyte pick up.

Exclusion Criteria

When oocyte pick up was stopped. No consent was obtained. Others deemed inappropriate by the attending physician.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath